Evestra out-licenses marketing rights for near-term product for Russia and CIS territories
Evestra out-licenses rest-of-the-world (ROW) marketing rights for near-term product
Evestra signs second R&D collaboration with RCPE, Graz to develop proprietary vaginal drug delivery technology
Evestra closes private offering raising $2.5 million
Evestra out-licenses European marketing rights for near-term product
Evestra receives a new contract from NIH to manufacture cGMP grade hormonal steroid
Evestra's second US patent issued
For more 2012 info, please click here.